{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:21:36Z","timestamp":1770988896714,"version":"3.50.1"},"reference-count":96,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Novartis Pharmaceuticals"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1080\/10428194.2016.1198959","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T07:14:05Z","timestamp":1470899645000},"page":"2739-2751","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Rationale and motivating factors for treatment-free remission in chronic myeloid leukemia"],"prefix":"10.1080","volume":"57","author":[{"given":"Lauren","family":"Caldemeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke P.","family":"Akard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,8,10]]},"reference":[{"key":"CIT0001","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Chronic Myelogenous Leukemia. Version 1.2016. [Internet]. Fort Washington, PA: National Comprehensive Cancer Network; 2015 Sept 9 [cited 2016 May 23]; Available from: www.nccn.org\/professionals\/physician_gls\/pdf\/cml.pdf."},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr060"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-011239"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70233-3"},{"key":"CIT0005","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.603.603","volume":"118","author":"Mahon FX","year":"2011","journal-title":"Blood"},{"key":"CIT0006","volume":"120","author":"Matsuki E","year":"2012","journal-title":"Blood"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483750"},{"key":"CIT0008","volume":"120","author":"Rea D","year":"2012","journal-title":"Blood"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.5797"},{"key":"CIT0010","volume":"122","author":"Mahon FX","year":"2013","journal-title":"Blood"},{"key":"CIT0011","volume":"99","author":"Saussele S","year":"2014","journal-title":"Haematologica"},{"key":"CIT0012","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.151.151","volume":"124","author":"Mahon FX","year":"2014","journal-title":"Blood"},{"key":"CIT0013","volume":"124","author":"Rea D","year":"2014","journal-title":"Blood"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00196-9"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.139899"},{"key":"CIT0016","volume":"126","author":"Mori S","year":"2015","journal-title":"Blood"},{"key":"CIT0017","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.345.345","volume":"126","author":"Etienne G","year":"2015","journal-title":"Blood"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.7757"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-301341"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03030-X"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-286310"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.1.214"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11223"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23902"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.01.033"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1988"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12892"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-158535"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.5"},{"key":"CIT0030","volume":"124","author":"Cortes JE","year":"2014","journal-title":"Blood"},{"key":"CIT0031","volume":"100","author":"Hughes TP","year":"2015","journal-title":"Haematologica"},{"key":"CIT0032","unstructured":"Ariad Pharmaceuticals. Iclusig [package insert] 2015."},{"key":"CIT0033","unstructured":"Pfizer Inc. Bosulif [package insert] 2016."},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13108"},{"key":"CIT0035","volume":"124","author":"Lipton JH","year":"2014","journal-title":"Blood"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-462291"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.36"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.9020"},{"key":"CIT0039","unstructured":"Novartis Pharmaceuticals Corporation. Gleevec [package insert] 2015."},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70201-7"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.134"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-510396"},{"key":"CIT0043","unstructured":"Bristol-Myers Squibb. Sprycel [summary of product characteristics] 2015."},{"key":"CIT0044","unstructured":"Novartis Pharmaceuticals Corporation Tasigna [package insert] 2015."},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.270"},{"key":"CIT0046","unstructured":"A multicenter phase 3, open-label study of bosutinib versus imatinib in adult patients with newly diagnosed chronic phase chronic myelogenous leukemia [Internet]. Bethesda, MD: ClinicalTrials.gov; 2015 Sept 16 [cited 2016 Apr 25]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02130557"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23728"},{"key":"CIT0048","volume":"124","author":"Cortes JE","year":"2014","journal-title":"Blood"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-598292"},{"key":"CIT0050","volume":"100","author":"Hughes TP","year":"2015","journal-title":"Haematologica"},{"key":"CIT0051","volume":"100","author":"le Coutre PD","year":"2015","journal-title":"Haematologica"},{"key":"CIT0052","volume":"124","author":"Tanimoto M","year":"2014","journal-title":"Blood"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.095158"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23560"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-280206"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12258"},{"key":"CIT0058","volume":"122","author":"Rea D","year":"2013","journal-title":"Blood"},{"key":"CIT0059","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.343.343","volume":"126","author":"Ilander M","year":"2015","journal-title":"Blood"},{"key":"CIT0060","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.599.599","volume":"126","author":"Burchert A","year":"2015","journal-title":"Blood"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.319"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-339267"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.41"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.45"},{"key":"CIT0065","unstructured":"Tasigna and interferon alpha evaluation initiated by the German Chronic Myeloid Leukemia Study Group\u2014the TIGER study [Internet]. Bethesda, MD: ClinicalTrials.gov; 2014 Dec 4 [cited2013 Sept 12]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01657604"},{"key":"CIT0066","unstructured":"Open-label study evaluating dasatinib therapy discontinuation in patients with chronic phase chronic myeloid leukemia with stable complete molecular response (DASFREE) [Internet]. Bethesda, MD: ClinicalTrials.gov; 2013 May 8 [cited2013 Sep 9]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01850004"},{"key":"CIT0067","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.4_suppl.11","volume":"32","author":"Mahon FX","year":"2014","journal-title":"J Clin Oncol"},{"key":"CIT0068","volume":"126","author":"Ritchie EK","year":"2015","journal-title":"Blood"},{"key":"CIT0069","volume":"126","author":"Rea D","year":"2015","journal-title":"Blood"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0092"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.29"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.69"},{"key":"CIT0073","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.6605","volume":"29","author":"Laneuville P","year":"2011","journal-title":"J Clin Oncol"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.079921"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-511592"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.9260"},{"key":"CIT0077","volume":"99","author":"Rousselot P","year":"2014","journal-title":"Haematologica"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.944973"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-477687"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347575"},{"key":"CIT0081","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.4547.4547","volume":"124","author":"Boquimpani CM","year":"2014","journal-title":"Blood"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.3858"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.6910"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1064531"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.3747\/co.21.1736"},{"key":"CIT0086","volume":"126","author":"Goldberg S","year":"2015","journal-title":"Blood"},{"key":"CIT0087","volume":"120","author":"Kyle RM","year":"2012","journal-title":"Blood"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-114900"},{"key":"CIT0089","volume":"112","author":"Cortes J","year":"2008","journal-title":"Blood"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24186"},{"key":"CIT0091","unstructured":"Bristol-Myers Squibb. Sprycel [package insert] 2015."},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-490003"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.9123"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23427"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-005686"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-163485"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tandfonline.com\/doi\/pdf\/10.1080\/10428194.2016.1198959","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2016.1198959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T02:41:31Z","timestamp":1601001691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2016.1198959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,10]]},"references-count":96,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,5,17]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1080\/10428194.2016.1198959"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2016.1198959","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}